Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Production and Quality Assurance of Human Polyclonal Hyperimmune Immunoglobulins Against SARS-CoV-2
Thierry Burnouf, Birgit Gathof, Evan M. Bloch, et al.
Transfusion Medicine Reviews (2022) Vol. 36, Iss. 3, pp. 125-132
Open Access | Times Cited: 12

Showing 12 citing articles:

Uses and Challenges of Antiviral Polyclonal and Monoclonal Antibody Therapies
Evi Struble, Jonathan Rawson, Tzanko S. Stantchev, et al.
Pharmaceutics (2023) Vol. 15, Iss. 5, pp. 1538-1538
Open Access | Times Cited: 13
The Potential Role of Passive Antibody-Based Therapies as Treatments for Monkeypox
Evan M. Bloch, David J. Sullivan, Shmuel Shoham, et al.
mBio (2022) Vol. 13, Iss. 6
Open Access | Times Cited: 19
Hyperimmune Globulins in COVID-19
‪Yasmin Maor‬‏, Oren Zimhony
Current topics in microbiology and immunology (2024)
Closed Access | Times Cited: 2
Managing blood supplies during natural disasters, humanitarian emergencies, and pandemics: lessons learned from COVID-19
Tayler A. Van Denakker, Arwa Z. Al‐Riyami, Rita Feghali, et al.
Expert Review of Hematology (2023) Vol. 16, Iss. 7, pp. 501-514
Closed Access | Times Cited: 7
SARS‐CoV‐2 neutralising antibody therapies: Recent advances and future challenges
Mingtao Liu, Zhiman Liang, Zhangkai J. Cheng, et al.
Reviews in Medical Virology (2023) Vol. 33, Iss. 5
Closed Access | Times Cited: 4
Passive antibody therapy in emerging infectious diseases
Xiaoming Yang
Frontiers of Medicine (2023) Vol. 17, Iss. 6, pp. 1117-1134
Closed Access | Times Cited: 3
Uses and Challenges of Antiviral Polyclonal and Monoclonal Antibody Therapies
Evi Struble, Jonathan Rawson, Tzanko S. Stantchev, et al.
(2023)
Open Access | Times Cited: 2
Towards personalized and rational use of immunoglobulins amid expanding indications and shortages
Hadi Goubran, Gaafar Ragab, Jerard Seghatchian, et al.
Transfusion and Apheresis Science (2024) Vol. 63, Iss. 5, pp. 103987-103987
Closed Access
The role of convalescent plasma and hyperimmune immunoglobulins in the COVID-19 pandemic, including implications for future preparedness
Cynthia So‐Osman, Thierry Burnouf, Arwa Z. Al‐Riyami, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Exploring the increasing need for plasma collection: Perspectives of voluntary nonremunerated donors on payment for plasma in Canada
Kelly Holloway
Transfusion Medicine (2023) Vol. 33, Iss. 5, pp. 390-397
Closed Access | Times Cited: 1
Validation of Viral Inactivation Protocols for Therapeutic Blood Products against Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)
Wendimi Fatimata Belem, Ching-Hsuan Liu, Yee-Tung Hu, et al.
Viruses (2022) Vol. 14, Iss. 11, pp. 2419-2419
Open Access | Times Cited: 1
WITHDRAWN: Payment and profit in Canada’s plasma collection system: a process evaluation of Canadian Blood Services effort to meet sufficiency
Kelly Holloway
Social Science & Medicine (2022), pp. 115453-115453
Closed Access
Page 1

Scroll to top